Depressive Symptoms and Clinical Status During the Treatment of Adolescent Suicide Attempters (TASA) Study

 This article was reviewed under and accepted by Ad Hoc Editor Garry Walter, M.D., Ph.D.Funded by the National Institute of Mental Health through cooperative agreement grants MH66750 (PI: K.W., Duke University Medical Center), MH66769 (PI;J. W, Johns Hopkins University), MH66762 (PI: I. G, New York State Psychiatric Institute), MH66775 (PI: D.B., University of Pittsburgh), and MH66778 (PI: G.B., University of Texas Southwestern Medical Center). Data management was funded by an NIMH contract to KAI Research, Rockville, MD.The opinions and assertions contained in this article are the private views of the authors and are not to be construed as official or as reflecting the views of the National Institute of Mental Health, the National Institutes of Health, or the Department of Health and Human Services.This article is the subject of an editorial by Dr. Garry Walter in this issue.The authors thank Brian Knizner (project coordinator), Marcie McCullough (data entry), Travis Schermer (interviewer), Angela Aloxe (interviewer), Kim Poling (therapy supervhor, therapist), Nancy Tormey (therapist), Brian McKain (pharma-cotherapht and therapist), Sue Wesner (pharmacotherapht), Allen Chrhman (psychiatrist, pharmacotherapy supervisor), Rameshari Tumuluru (psychiatrist), John Campo (psychiatrist), Joanne Severe (operations), and the NIMH Data and Safety Monitoring Board.Clinical trial registration information–Treatment of Adolescent Suicide Attempters (TASA). URL: http://clinicaltrials.gov. Unique identifier: NCT00080158.

PII: S0890-8567(09)60164-7

doi: 10.1097/CHI.0b013e3181b5db66

© 2009 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.